Disparities in outcomes for patients with multiple myeloma have been linked to socioeconomic barriers. This study, published in Leukemia Research, aimed to provide further insight into the nature of these disparities to ensure equitable treatment. Specifically, the study focuses on the association between insurance status and survival in patients with multiple myeloma.
This study relied on data from the 2007-2016 Surveillance, Epidemiology, and End Results Program database. Insurance status for the 41,846 study participants was divided between uninsured, Medicaid, private insurance, and other. Cancer-specific survival was measured for the participants in these groups at one and five years after diagnosis.
After adjusting for various demographic factors, including age, ethnicity, race, sex, marital status, and residence, the researchers found that patients in the Medicaid group exhibited significantly lower five-year survival rates than those in the private insurance group. And, the uninsured group, which had the highest proportion of Black patients, had a 26% greater mortality hazard than the private insurance group.
The researchers concluded that insurance status can influence the survival rates of adults with multiple myeloma. They further note that insurance status should not be a barrier to treatment, especially as treatment continues to advance .
Source: Makhani, S. S., Shively, D., Castro, G., Rodriguez De La Vega, P., & Barengo, N. C. (2021). Association of insurance disparities and survival in adults with multiple myeloma: a non-concurrent cohort study. Leukemia Research, 104, 106542. https://doi.org/10.1016/j.leukres.2021.106542